Filing Impact
Filing Sentiment
Form Type
1-A
Analyzing...
Dare Bioscience Inc
Nov 13, 2025
[8-K] Dare Bioscience, Inc. Reports Material Event
Oct 6, 2025
[SCHEDULE 13G] Dare Bioscience, Inc. SEC Filing
27.86M
13.04M
1.03%
6.71%
1.46%
Biotechnology
Pharmaceutical Preparations
United States
SAN DIEGO